First Report of CTX-M-15 Salmonella Typhi From England.
暂无分享,去创建一个
S. Nair | G. Godbole | M. Chattaway | M. Day | S. Murthy
[1] U. Spengler,et al. Successful Therapy of a Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing and Fluoroquinolone-Resistant Salmonella enterica Subspecies enterica Serovar Typhi Infection Using Combination Therapy of Meropenem and Fosfomycin. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] Gemma C. Langridge,et al. WGS for surveillance of antimicrobial resistance: a pilot study to detect the prevalence and mechanism of resistance to azithromycin in a UK population of non-typhoidal Salmonella. , 2016, The Journal of antimicrobial chemotherapy.
[3] J. Wain,et al. Rapid Identification of Major Escherichia coli Sequence Types Causing Urinary Tract and Bloodstream Infections , 2014, Journal of Clinical Microbiology.
[4] M. Albert,et al. Emergence of CTX-M-15 type extended-spectrum beta-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates. , 2008, Journal of medical microbiology.